The development division for innovative biomarkers and technologies – miRNA, NGS, liquid biopsies and immunodiagnostic automation.
Since its founding in 1995, our Biovendor R&D division has been dedicated to research. It continues its efforts in development, production and distribution of immunodiagnostic and molecular diagnostic products in more than 25 clinical areas. Each one of our 70 employees makes the development of almost 200 immunodiagnostic ELISA kits possible.
One of the pillars of our activity is the introduction of the results of basic research into routine diagnostics. We cooperate with research and scientific institutions, we are members of professional consortia – we help direct scientific activities to address the needs of immunodiagnostic practice. We are currently focusing on two main areas: exploiting the diagnostic potential of microRNAs and introducing automated solutions for innovative biomarkers.